Preclinical

 

Aurora’s CAR T Cell agents AU101 and AU105 targeting HER-2 and other co-stimulatory tumor agents have shown it can kill solid tumor cancers in various types of tumors. The treated xenograft mice saw their tumors eradicated, and lived, while the untreated control animals all progressed and perish.